InhaleRx Ltd News

InhaleRx Ltd: Results of General Meeting

Nov 29 05:35

InhaleRx Ltd: Nov24 EGM Slides

Nov 28 13:09

InhaleRx Ltd: Director Appointment and Resignation

Nov 28 07:12

InhaleRx Ltd: Ethics Approval for Phase 2 Clinical Trial of IRX-211

Nov 15 06:33

InhaleRx Ltd: Change in substantial holding - Cannvalate

Nov 14 07:55

InhaleRx Ltd: Sep24 Appendix 4C Cash Flow Report

Oct 31 17:03

InhaleRx Ltd: Sep24 Quarterly Activities Report

Oct 31 17:03

InhaleRx Ltd: General Meeting - Access Letter

Oct 29 06:09

InhaleRx Ltd: Notice of General Meeting

Oct 29 06:08

InhaleRx Ltd: General Meeting - Sample Proxy

Oct 29 06:06

InhaleRx Ltd: Change in substantial holding

Oct 28 16:06

InhaleRx Ltd: Application for quotation of securities - IRX

Oct 24 12:28

InhaleRx Ltd: Cleansing Notice

Oct 23 10:28

InhaleRx Ltd: Issue of Loan Conversion shares

Oct 23 09:04

InhaleRx Ltd: Proposed issue of securities - IRX

Oct 23 09:01

InhaleRx Ltd: Proposed issue of securities - IRX

Oct 18 07:25

InhaleRx Ltd: $38.5m Funding to Fully Fund Clinical Development Plans

Oct 18 07:11

InhaleRx Ltd: Application for quotation of securities - IRX

Oct 3 15:55

InhaleRx Ltd: Proposed issue of securities - IRX

Oct 2 08:03

InhaleRx Ltd: Issue of Shares to CEO in Lieu of Accrued Salary

Oct 2 08:02